Kang H. Zheng

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Which aldosterone antagonist? Choosing between sprionolactone and the novel drug finerenone

Which aldosterone antagonist? Choosing between sprionolactone and the novel drug finerenone

Journal: Nederlands tijdschrift voor geneeskunde

Published: June 15, 2026

Aortic valve stenosis in 2026: from emerging mechanisms to clinical drug development.

Aortic valve stenosis in 2026: from emerging mechanisms to clinical drug development.

Journal: Atherosclerosis

Published: February 02, 2026

Fuelling aortic stenosis: the integral role of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3-mediated glycolysis in Lp(a)-induced valve inflammation.

Fuelling aortic stenosis: the integral role of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3-mediated glycolysis in Lp(a)-induced valve inflammation.

Journal: European heart journal open

Published: March 05, 2025

First-in-human study of 99mTc-labeled fucoidan, a SPECT tracer targeting P-selectin.

First-in-human study of 99mTc-labeled fucoidan, a SPECT tracer targeting P-selectin.

Journal: EJNMMI research

Published: August 15, 2024

Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression: A Systematic Review and Meta-Analysis.

Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression: A Systematic Review and Meta-Analysis.

Journal: JAMA cardiology

Published: July 17, 2024

Lipoprotein(a) and peri-coronary adipose tissue.

Lipoprotein(a) and peri-coronary adipose tissue.

Journal: European heart journal. Cardiovascular Imaging

Published: June 30, 2024

Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease.

Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease.

Journal: Circulation

Published: November 08, 2023

Accumulation of Iron Oxide-Based Contrast Agents in Rabbit Atherosclerotic Plaques in Relation to Plaque Age and Vulnerability Features.

Accumulation of Iron Oxide-Based Contrast Agents in Rabbit Atherosclerotic Plaques in Relation to Plaque Age and Vulnerability Features.

Journal: International journal of nanomedicine

Published: July 14, 2023

Peripheral Ischemia Imprints Epigenetic Changes in Hematopoietic Stem Cells to Propagate Inflammation and Atherosclerosis.

Peripheral Ischemia Imprints Epigenetic Changes in Hematopoietic Stem Cells to Propagate Inflammation and Atherosclerosis.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: March 09, 2023

Comparative in vitro and in vivo Evaluation of Different Iron Oxide-Based Contrast Agents to Promote Clinical Translation in Compliance with Patient Safety.

Comparative in vitro and in vivo Evaluation of Different Iron Oxide-Based Contrast Agents to Promote Clinical Translation in Compliance with Patient Safety.

Journal: International journal of nanomedicine

Published: January 09, 2023

Serum lipoprotein(a) and bioprosthetic aortic valve degeneration.

Serum lipoprotein(a) and bioprosthetic aortic valve degeneration.

Journal: European heart journal. Cardiovascular Imaging

Published: November 16, 2022

Lipoprotein(a) and Aortic Valve Calcification: The Multi-Ethnic Study of Atherosclerosis.

Lipoprotein(a) and Aortic Valve Calcification: The Multi-Ethnic Study of Atherosclerosis.

Journal: JACC. Cardiovascular imaging

Published: May 02, 2022

Showing 1-12 of 39

Last Updated: 09/26/2026